ADMA Biologics (ADMA)
NASDAQ:ADMA
US Market
Holding ADMA?
Track your performance easily

ADMA Biologics (ADMA) Financial Statements

2,703 Followers

ADMA Biologics Financial Overview

ADMA Biologics's market cap is currently ―. The company's EPS TTM is $0.14; its P/E ratio is 160.88; ADMA Biologics is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $0.15. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 119.84M$ 107.19M$ 81.88M$ 73.90M$ 67.27M
Gross Profit$ 59.66M$ 57.45M$ 39.11M$ 31.09M$ 24.65M
EBIT$ 36.71M$ 35.86M$ 22.16M$ -11.43M$ 8.96M
EBITDA$ 38.87M$ 38.10M$ 24.49M$ -9.32M$ 11.06M
Net Income Common Stockholders$ 35.91M$ 32.06M$ 17.81M$ -17.64M$ 2.57M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 86.70M$ 88.20M$ 45.33M$ 51.35M$ 74.16M
Total Assets$ 390.62M$ 376.40M$ 350.88M$ 329.18M$ 349.00M
Total Debt$ 111.38M$ 141.40M$ 141.43M$ 141.42M$ 152.97M
Net Debt$ 24.68M$ 53.20M$ 96.10M$ 90.07M$ 78.82M
Total Liabilities$ 158.73M$ 188.13M$ 197.17M$ 193.98M$ 197.56M
Stockholders Equity$ 231.89M$ 188.27M$ 153.71M$ 135.21M$ 151.44M
Cash Flow-
Free Cash Flow$ 23.93M$ 43.28M$ -4.58M$ 16.19M$ 11.23M
Operating Cash Flow$ 25.03M$ 45.65M$ -2.22M$ 17.60M$ 11.99M
Investing Cash Flow$ -1.10M$ -2.37M$ -2.36M$ -1.41M$ -756.56K
Financing Cash Flow$ -25.47M$ -362.00K$ -1.45M$ -38.99M$ 415.36K
Currency in USD

ADMA Biologics Earnings and Revenue History

ADMA Biologics Debt to Assets

ADMA Biologics Cash Flow

ADMA Biologics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis